Investors Press Releases Jun 17 2022 Tiziana Life Sciences Ltd. Receives Nasdaq Deficiency Notice Read More Jun 09 2022 Tiziana Life Sciences PLC (TLSA: NASDAQ) Releases Research Report: Clinical Improvements for 2nd SPMS Patient Read More Jun 09 2022 Tiziana Life Sciences Announces An Interview on Clinical Improvements for 2nd SPMS Patient Read More btn News View All Events & Presentations Jun 14 2022 at 2:00 PM PDT Jun 14 2022 at 2:00 PM PDT Tiziana Life Sciences to Present at the 2022 Biotechnology Innovation Organization Annual Convention Read More Apr 27 2022 at 2:30 PM EDT Apr 27 2022 at 2:30 PM EDT Tiziana Life Sciences to Present at the B. Riley Securities 2022 Virtual Neuro & Ophthalmology Conference Read More Mar 14 2022 at 11:00 AM EDT Mar 14 2022 at 11:00 AM EDT Tiziana Life Sciences KOL Event - Foralumab Clinical Update in Multiple Sclerosis; A Landmark Study with Intranasal Immunotherapy featuring 4 Key Opinion Leaders Read More btn Events View All Interim Reports Interim Results for the Six Months Ended 30 June 2021 563.4 KB bth Interim Reports View All Annual Reports 20 F - Annual Report for the year ended 31 December 2021 1.9 MB btn ARs View All Annual General Meeting Results of General Meeting September 2021 129.9 KB btn AGM View All Scientific Pipeline Progress Learn more × Stock Quote Change Volume Today's Open Previous Close Today's High Today's Low 52 Week High 52 Week Low Stock Chart
Jun 09 2022 Tiziana Life Sciences PLC (TLSA: NASDAQ) Releases Research Report: Clinical Improvements for 2nd SPMS Patient Read More
Jun 09 2022 Tiziana Life Sciences Announces An Interview on Clinical Improvements for 2nd SPMS Patient Read More
Jun 14 2022 at 2:00 PM PDT Jun 14 2022 at 2:00 PM PDT Tiziana Life Sciences to Present at the 2022 Biotechnology Innovation Organization Annual Convention Read More
Apr 27 2022 at 2:30 PM EDT Apr 27 2022 at 2:30 PM EDT Tiziana Life Sciences to Present at the B. Riley Securities 2022 Virtual Neuro & Ophthalmology Conference Read More
Mar 14 2022 at 11:00 AM EDT Mar 14 2022 at 11:00 AM EDT Tiziana Life Sciences KOL Event - Foralumab Clinical Update in Multiple Sclerosis; A Landmark Study with Intranasal Immunotherapy featuring 4 Key Opinion Leaders Read More